Adrian Patasar - DNA Brands Chief Officer
| DNAX Stock | USD 0.0002 0.0001 100.00% |
Insider
Adrian Patasar is Chief Officer of DNA Brands
| Age | 47 |
| Phone | 954-368-3272 |
| Web | https://www.dnabrandsinc.com |
Similar Executives
| Showing other executives | INSIDER Age | ||
| Justine Tan | Keurig Dr Pepper | 46 | |
| Hany Mikhail | Zevia Pbc | 52 | |
| Anthony Shoemaker | Keurig Dr Pepper | 41 | |
| Nelson Urdaneta | Keurig Dr Pepper | 47 | |
| Tony Milikin | Keurig Dr Pepper | 60 | |
| Denise Beckles | Zevia Pbc | N/A | |
| Mary DeNooyer | Keurig Dr Pepper | 54 | |
| Jonathan Burth | Vita Coco | 42 | |
| Charles Es | Vita Coco | 47 | |
| Stephanie Schonauer | Zevia Pbc | N/A | |
| Debra Sandler | Keurig Dr Pepper | 60 | |
| Quincy Troupe | Zevia Pbc | 58 | |
| Stephanie Yuen | Zevia Pbc | N/A | |
| Lubomira Rochet | Keurig Dr Pepper | 43 | |
| Mauricio Arboleda | Keurig Dr Pepper | 54 | |
| Monique Oxender | Keurig Dr Pepper | 48 | |
| Juliette Hickman | Keurig Dr Pepper | 46 | |
| Martin Roper | Vita Coco | 61 | |
| Justin Whitmore | Keurig Dr Pepper | 41 | |
| Michael Call | Keurig Dr Pepper | 48 | |
| Ira Liran | Vita Coco | 45 | |
DNA Brands Leadership Team
Elected by the shareholders, the DNA Brands' board of directors comprises two types of representatives: DNA Brands inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DNA. The board's role is to monitor DNA Brands' management team and ensure that shareholders' interests are well served. DNA Brands' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DNA Brands' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ralph Sabella, VP Operations | ||
| Howard Ullman, President | ||
| Andrew Ferrin, Chief Officer | ||
| Adrian Patasar, Chief Officer |
DNA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is DNA Brands a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Operating Margin | (0.98) % | |||
| Current Valuation | 1.47 M | |||
| Shares Outstanding | 22.07 K | |||
| Price To Earning | 0.20 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 249.01 K | |||
| Gross Profit | 249.01 K | |||
| EBITDA | (239.66 K) | |||
| Net Income | (1.25 M) | |||
| Cash And Equivalents | 499 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for DNA Pink Sheet Analysis
When running DNA Brands' price analysis, check to measure DNA Brands' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Brands is operating at the current time. Most of DNA Brands' value examination focuses on studying past and present price action to predict the probability of DNA Brands' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Brands' price. Additionally, you may evaluate how the addition of DNA Brands to your portfolios can decrease your overall portfolio volatility.